Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
NGS Liquid Biopsy Solution for Highly Sensitive MRD Detection
A clinical validation summary of a high performing liquid biopsy assay
Download
In this Application Note, learn how IntegraGen, an OncoDNA Group company, utilized Twist NGS products to validate their highly sensitive minimal residual disease (MRD) assay.
Covered in this Application Note
How IntegraGen achieved a limit of detection (LoD) of 0.003% using an NGS-based workflow.
IntegraGen’s panel design strategy for targeting up to 119 tumor-specific variants per patient.
How Twist products used as a workflow helped IntegraGen achieve their results.
Share your details to Get the Application Note